Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer

Cancer Biomarkers

Volumn 15, Issue 6, 2015, Pages 899-907

  Lian, Lian ^a,b   Xia, You You ^c,d   Zhou, Chong ^e   Shen, Xiao Ming ^b   Li, Xiang Li ^b   Han, Shu Guang ^b   Zheng, Yan ^b   Mao, Zhong Qi ^a   Gong, Fei Ran ^a   Wu, Meng Yao ^a   Chen, Kai ^a   Tao, Min ^a,f,g   Li, Wei ^a,g  

^a THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b Department of Oncology Suzhou Xiangcheng People's Hospital   (China)

^c Lianyungang First People's Hospital   (China)

^d NANJING MEDICAL UNIVERSITY   (China)

^e XUZHOU CENTRAL HOSPITAL   (China)

^f Institute of Clinical Immunology of Jiangsu Province   (China)

^g SOOCHOW UNIVERSITY   (China)

Author keywords

Gastric cancer; neutrophil to lymphocyte ratio (NLR); platelet to lymphocyte ratio (PLR)

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; FEMALE; HUMAN; INFLAMMATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PLATELET LYMPHOCYTE RATIO; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH CANCER; SURVIVAL PREDICTION; TUMOR INVASION; ADENOCARCINOMA; CASE CONTROL STUDY; FOLLOW UP; LYMPHOCYTE; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; PROGNOSIS; SECONDARY; STOMACH NEOPLASMS; THROMBOCYTE; VERY ELDERLY;

TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; BLOOD PLATELETS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84949229357     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-150534     Document Type: Article

References (37)

1. Shen L, Shan YS, Hu HM, Price TJ, Sirohi B, Yeh KH, et al. Management of gastric cancer in Asia: Resource-stratified guidelines. The Lancet Oncology 2013; 14(12): e535-47.
2. Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, et al. Screening for gastric cancer in Asia: Current evidence and practice. The Lancet Oncology 2008; 9(3): 279-87.
3. McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Current Opinion in Clinical Nutrition and Metabolic Care 2009; 12(3): 223-6.
4. Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O'Reilly DS, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer 2011; 47(17): 2633-41.
5. Roxburgh CS, Salmond JM, Horgan PG, Oien KA, McMillan DC. Comparison of the prognostic value of inflammationbased pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Annals of Surgery 2009; 249(5): 788-93.
6. Ilhan N, Ilhan Y, Akbulut H, Kucuksu M. C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer. World Journal of Gastroenterology: WJG 2004; 10(8): 1115-20.
7. Kim DK, Oh SY, Kwon HC, Lee S, Kwon KA, Kim BG, et al. Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in resectable gastric cancer. BMC Cancer 2009; 9: 155.
8. Kilincalp S, Ekiz F, Basar O, AyteMR, Coban S, Yilmaz B, et al. Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer. Platelets 2014; 25(8): 592-4.
9. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. Journal of Surgical Oncology 2005; 91(3): 181-4.
10. Gwak MS, Choi SJ, Kim JA, Ko JS, Kim TH, Lee SM, et al. Effects of gender on white blood cell populations and neutrophil-lymphocyte ratio following gastrectomy in patients with stomach cancer. Journal of Korean Medical Science 2007; 22 Suppl: S104-8.
11. Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F, et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. American Journal of Surgery 2009; 197(4): 466-72.
12. Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, Neugut AI, et al. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Annals of Surgical Oncology 2011; 18(12): 3362-9.
13. Thavaramara T, Phaloprakarn C, Tangjitgamol S, Manusirivithaya S. Role of neutrophil to lymphocyte ratio as a prognostic indicator for epithelial ovarian cancer. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2011; 94(7): 871-7.
14. Kemal Y, Yucel I, Ekiz K, Demirag G, Yilmaz B, Teker F, et al. Elevated serum neutrophil to lymphocyte and platelet to lymphocyte ratios could be useful in lung cancer diagnosis. Asian Pacific journal of cancer prevention: APJCP 2014; 15(6): 2651-4.
15. Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T, et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Annals of surgical oncology 2012; 19(1): 217-24.
16. Seretis C, Seretis F, Lagoudianakis E, Politou M, Gemenetzis G, Salemis NS. Enhancing the accuracy of platelet to lymphocyte ratio after adjustment for large platelet count: A pilot study in breast cancer patients. International Journal of Surgical Oncology 2012; 2012: 653608.
17. Edge SB, Compton CC. The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of Surgical Oncology 2010; 17(6): 1471-4.
18. Carruthers R, Tho LM, Brown J, Kakumanu S, McCartney E, McDonald AC. Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Colorectal disease: The official journal of the Association of Coloproctology of Great Britain and Ireland 2012; 14(10): e701-7.
19. Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: Integrating immunitys roles in cancer suppression and promotion. Science 2011; 331(6024): 1565-70.
20. Yavuzcan A, Caglar M, Ustun Y, Dilbaz S, Ozdemir I, Yildiz E, et al. Evaluation of mean platelet volume, neutrophil/ lymphocyte ratio and platelet/lymphocyte ratio in advanced stage endometriosis with endometrioma. Journal of the Turkish German Gynecological Association 2013; 14(4): 210-5.
21. Malik HZ, Prasad KR, Halazun KJ, Aldoori A, Al-Mukhtar A, Gomez D, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Annals of Surgery 2007; 246(5): 806-14.
22. Ding PR, An X, Zhang RX, Fang YJ, Li LR, Chen G, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer. International journal of Colorectal Disease 2010; 25(12): 1427-33.
23. Liu H, Liu G, Bao Q, Sun W, Bao H, Bi L, et al. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in rectal carcinoma. Journal of Gastrointestinal Cancer 2010; 41(2): 116-20.
24. Bazou D, Santos-Martinez MJ, Medina C, Radomski MW. Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap. British Journal of Pharmacology 2011; 162(7): 1577-89.
25. Shou LM, Zhang QY, LiW, Xie X, Chen K, Lian L, et al. Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of alpha2 integrin. Oncology Reports 2013; 30(3): 1059-66.
26. Bambace NM, Holmes CE. The platelet contribution to cancer progression. Journal of thrombosis and haemostasis: JTH 2011; 9(2): 237-49.
27. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. The American Journal of Pathology 1995; 146(5): 1029-39.
28. Benoy I, Salgado R, Colpaert C, Weytjens R, Vermeulen PB, Dirix LY. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clinical Breast Cancer 2002; 2(4): 311-5.
29. Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. Journal of interferon & cytokine research: The official journal of the International Society for Interferon and Cytokine Research 2002; 22(9): 913-22.
30. Alexandrakis MG, Passam FH, Moschandrea IA, Christophoridou AV, Pappa CA, Coulocheri SA, et al. Levels of serum cytokines and acute phase proteins in patients with essential and cancer-related thrombocytosis. American Journal of Clinical Oncology 2003; 26(2): 135-40.
31. Ashizawa T, Okada R, Suzuki Y, TakagiM, Yamazaki T, Sumi T, et al. Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor. Gastric cancer: Official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2005; 8(2): 124-31.
32. Heras P, Hatzopoulos A, Kritikos N, Kritikos K. Platelet count and tumor progression in gastric cancer patients. Scandinavian Journal of Gastroenterology 2010; 45(7-8): 1005-6.
33. Hurst NJ, Jr., Najy AJ, Ustach CV, Movilla L, Kim HR. Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: Implications for breast cancer progression. The Biochemical journal 2012; 441(3): 909-18.
34. Lee Y, Kim SH, Han JY, Kim HT, Yun T, Lee JS. Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy. Journal of Cancer Research and Clinical Oncology 2012; 138(12): 2009-16.
35. Milne K, Alexander C, Webb JR, Sun W, Dillon K, Kalloger SE, et al. Absolute lymphocyte count is associated with survival in ovarian cancer indenpendent of tumor-infiltrating lymphocytes. Journal of Translational Medicine 2012; 10: 33.
36. Kobayashi N, Usui S, Kikuchi S, Goto Y, Sakai M, Onizuka M, et al. Preoperative lymphocyte count is an independent prognostic factor in node-negative non-small cell lung cancer. Lung Cancer 2012; 75(2): 223-7.
37. Kitayama J, Yasuda K, Kawai K, Sunami E, Nagawa H. Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer. Radiat Oncol 2010; 5: 47.